Point of Care Testing market and Roche

Transcription

1 US Point of Cae Oveview Rod Cotton Vice Pesident and Geneal Manage Point of Cae, USA 1 Point of Cae Testing maket and Roche Stategy and futue dives 2 Roche US Event Cotton, Point-of-Cae 1

2 Point-of-Cae Testing (POC): Definition Immediately actionable healthcae infomation outside cental lab fom diagnosis, to monitoing, to theapy adjustment ADMIT MOVE DISCHARGE Point-of-Cae Testing On-site testing: fom the hospital to the home Tests answeing ugent questions: acute and chonic conditions diagnosis and theapeutic monitoing Specific test needs: fast Simple-to-use technology eliable and epoducible esults PREVENTION CURE 3 Thee key custome segments Impoving clinical and economic outcomes acoss the continuum of cae "Reactive" Cae Theapy monitoing Monitoing and pevention Hospital Fast theapy adjustment Citical Cae Wok Aea Pimay Cae Compliance / Convenience eal-time theapy adjustment Physician s Office Wok Aea Patient Monitoing Compliance / Convenience eal-time theapy adjustment Patient Self-Testing Defined by medical indications Decentalized hospital testing of selected paametes POCT used to test whole blood samples in key locations thoughout the hospital Defined by key MD use goups Cadiologists Inten. Medicine Physician Geneal Pactitione CLIA waived POCT systems used fo patient sceening, theapy and monitoing activities and decisions Defined by patient Evolving teatment model (e.g. anticoagulation fom clinics to the patient's home) Whole blood samples (less invasive) POCT using the blood glucose monitoing appoach 4 Roche US Event Cotton, Point-of-Cae 2

3 Rapid maket gowth Diven by clinical, social and economic pessues coupled with new technologies and IT capabilities Govenment/ Political Focused on educing hospital length of stay and patient teatment via out-patient cae models (clinic, homecae, etc) Clinical/ economic outcomes Focused on enabling and quantifying value of moe effective and efficient cae (e.g. TGC, NICU Billiubin, PST-coag) Technology Making lab-quality tests available close to patient (MD office, patient home, ICU) and deliveed by non-laboatoy pesonnel POCT Maket Dives Decision makes Physicians, lab diectos, nuses, point of cae coodinatos, hospital administation, IT depatments Social/ economic pessue Inceased patient empowement and health consciousness Thid-paty payes diving impovements in compliance and oveall cost healthcae eductions Infomation Technology Inceased use of EMR s and othe data mgt. tools to captue all testing and associated costs thoughout healthcae system Focused on faste delivey of test esults to dive faste theapeutic intevention 5 Dynamic and gowing maket Select segments offeing double-digit gowth Majo segments US POCT Maket 2003 though 2008 (m USD) Total POCT* Dedicated Pofessional Glucose Testing Blood Gas/Electolytes Coagulation Cadiac Makes Dedicated Pimay Cae Systems (Lipids, HbA1c) Uinalysis 1, CAGR [%] ,288 E * Does not include manual tests e.g. pegnancy, infectious diseases and STD Souce: Boston Biomedical Consultants, EAC Study, Roche eseach 6 Roche US Event Cotton, Point-of-Cae 3

4 Roche Point of Cae Boadest decentalized testing menu Competitive Landscape Company Roche Abbott BGE Metabolites bg HbA 1C * CM Stoke planned Lipids & Othes PT ACT APTT UA Abaxis Axis Shield D-Dime Baye Biosite expected Cholestech Dade Behing IL expected ITC Akay / Menaini Elect. Nova Biomedical Radiomete Souce: Povalis * poduct in Centalized business aea; Roche majo manufactue fo othe Diagnostic companies 7 The boadest potfolio Addessing Point of Cae Testing custome needs Makets Life Science Pofessional Patient Cae Customes Reseach Molecula Lab Cental Lab STAT Lab HosPoC POL Patient Mon. Mgmt. BAs RAS RMD RCD RNP (POCT) RDC Businesses Hosp. Glu. Hosp. POC Pimay Cae Coag. Mon. Poduct Lines OMNI Systems IT Solutions Accu-Chek Glucose Accu-Chek Infom Cadiac Reade Uisys 1100 Accutend GC(T) Refloton Systems CoaguChek S Life Science Pofessional Patient Cae 8 Roche US Event Cotton, Point-of-Cae 4

5 Roche maintains oveall shae leadeship Among key diagnostic manufactues, Roche clea maket leade in 2 of the 4 majo POCT segments U.S. POCT Maket bn USD (+8 %) Dedicated Pofessional Glucose Testing Roche 19 % Blood Gas/ Electolytes Coagulation Othes 81 % Cadiac Makes Roche Abbott J&J Biosite Baye Souce: Boston Biomedical Consultants, EAC Study, Roche analysis 9 Point of Cae Testing maket and Roche Stategy and futue dives 10 Roche US Event Cotton, Point-of-Cae 5

6 Stategic impeatives to succeed in U.S. Dive decentalization of testing Stetch Dive testing fom lab to patient self-testing (pevention e.g. PST-Coagulation) Delive poducts and sevices enabling individualized testing and theapy Shape Innovative use of infomation and technology to alte clinical pactice and impove economic outcome Leveage each and penetation though acquisitions and alliances to expand offeings Stengthen Coe business Futue gowth dives New makets Gow maket shae with innovative new solutions and movement of tests fom lab close to the patient Leveage temendous maket shae, gowth, distibution model, installed IT systems and othe assets to expand penetation acoss test segments 11 Diving decentalized testing Focus investments on both shot and long-tem oppotunities acoss the continuum of cae Lab Hospital POC POL/ Clinic Inteim/ Off-site Home Incease investment in stand-alone POC business Develop stong clinical and economic souces of data to quantify value Expand poduct potfolio tied to unmet custome needs 12 Roche US Event Cotton, Point-of-Cae 6

7 Roche Point-of-Cae Globally aligned and focused on gowth Histoically, 3 sepaate businesses focused on poducts Today, 1 business focused on key disease and teatment segments Cae Hospital Goup (DCHG) Hospital Point of Cae (HPOC) Nea Patient Testing (NPT) Point of Cae DCHG Hospital bg Stips Metes Lancets NPT Coag (stips/metes) UA/Pimay Cae Cadiac Elecsys/Intega HPOC BGE Instuments Reagents Diseases Cadiac Cadiovascula Cance Metabolic Teatment Segments Point of Cae Monitoing Acute Intensive Cae Ambulatoy Cae 13 Best-in-Class: Ou advantage We will use ou stong leadeship position in POC Glucose and Coagulation Monitoing to dive futue gowth Assets People Highest ated POC sales and sevice team Passion fo the Point-of-Cae oppotunity Leadeship Histoy of POC shae leadeship Boadest POC potfolio offeing Long-standing POC custome elationships Potfolio Histoy of technology innovation R&D esouces to maintain stong potfolio Stuctue Globally aligned and focused Reach/ Distibution Most widely contacted with National GPO s Most widely contacted in distibution 14 Roche US Event Cotton, Point-of-Cae 7

8 Maket leading potfolio and assets Ou lead in each, innovation, eputation and pefomance today Blood Glucose Cadiovascula Coagulation Monitoing Intensive Cae Blood Gas Electolyte Cadiac Cadiac Makes Accu-Chek Infom System Hospital shae leade #1 poduct #1 sales foce #1 sevice #1 GPO each #1 Connectivity Coagu-Chek System Stategic Leveage 90% POL shae #1 poduct Lagest sales foce #1 sevice Complete coag monitoing potfolio Omni-S System Dive Gowth Configuable system Supeio IT solutions Innovative featues Remote QC mgt. Cadiac Reade System 1st cadiac apid assay Only company with POC and lab cadiac makes Novel expandable technology (Myoglobin, TnT) 15 Ensuing futue gowth Poducts in development. Ou innovation to ensue leading position and poducts tomoow Blood Glucose Cadiovascula Coagulation Monitoing Intensive Cae Blood Gas Electolyte Cadiac Cadiac Makes Wieless RF Testing System Coagu-Chek System Next Geneation BGE System Cadiac Reade System Note: Above illustations ae fo illustative pupose only and ae not be intepeted to epesent cuent o futue poducts 16 Roche US Event Cotton, Point-of-Cae 8

9 Stategic impeatives Impeatives Dive decentalization of testing fom lab to patient Actions Invest in health economics to povide evidence of bette patient and economic outcomes Dive adoption of cae standads acoss the POC testing spectum Obtain expanded eimbusement fo patient coagulation selfmonitoing Obtain PST specific CPT Codes Secue expanded indication coveage Leveage stong Hospital position (blood glucose, IT connectivity) to gow BGE and CVD businesses Expand Hospital blood glucose Incease OMNI S penetation Launch NT-poBNP on cadiac eade 17 Roche US Event Cotton, Point-of-Cae 9